• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia

Trendingnow

1

MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last year

2

Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic

3

Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurants

1

MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last year

2

Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic

3

Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurants
CommentaryCOVID-19 vaccines

How to accelerate the far-too-slow COVID vaccine rollout

By
Oliver Kharraz
Oliver Kharraz
Down Arrow Button Icon
By
Oliver Kharraz
Oliver Kharraz
Down Arrow Button Icon
January 21, 2021, 12:30 PM ET
Staff and volunteers distribute the COVID-19 vaccine at a mass-vaccination site in Los Angeles. To get the rollout right, writes Oliver Kharraz, “We should allow all qualified providers, regardless of specialty, to administer the vaccine.”
Staff and volunteers distribute the COVID-19 vaccine at a mass-vaccination site in Los Angeles. To get the rollout right, writes Oliver Kharraz, “We should allow all qualified providers, regardless of specialty, to administer the vaccine.”Al Seib—Los Angeles Times/Getty Images
Add Fortune on Google for similar content.

Many years from now, when the trauma of the COVID-19 pandemic is behind us, we will look back and recognize 2020 as a turning point in the science of vaccines. The achievements of research and manufacturing executives at companies like Pfizer and Moderna are nothing short of incredible.

Those achievements deserve a distribution strategy that matches their speed and effectiveness. So far, that strategy has fallen woefully short. The federal government set a goal to administer 20 million doses by the end of 2020. We administered only 2.1 million. States have adopted ad hoc and often counterproductive distribution schemes. If the current pace continues, it will take years to reach herd immunity and return to normal. 

As the incoming Biden administration takes the reins on our nation’s vaccination program, it will be interesting to see how a new, federally directed plan accelerates vaccinations to the pace that will be necessary to overcome the pandemic this year.

But one thing is certain: As we untangle an overwhelmingly complex logistical problem, it is incumbent upon both the public and private sectors to get this right. Tens of thousands of lives are at stake. As someone who has spent 13 years focused on health care logistics, especially the mismatch between health care supply and demand, I have a few recommendations that will help to ensure that vaccination distribution runs smoothly.

Expand the capacity of our health care system

America’s health care system typically supports 1.2 billion doctor visits each year. Even at that level, many offices and regions are strained for capacity. It takes, on average, 29 days for a patient to actually see a doctor after an initial call. 

The vaccination program is a demand shock. For effective immunity in the U.S., we need to vaccinate 200 million people, or approximately 70% of the population. That requires 400 million new patient interactions for a two-dose vaccine. This represents a 33% increase in care encounters—happening, of course, under incredible time pressure. We must think creatively about how to create more capacity. 

In a system with high demand and low supply, it is essential to minimize bottlenecks and single points of failure. While we should commend leading pharmacies like CVS and Walgreens for stepping up to the challenge, it would be a mistake to rely on them and a handful of others alone. 

To quickly vaccinate the American population, we must broaden the number of distribution points. To do that, we should be ready to leverage all levels of our existing health care infrastructure, including ambulatory care settings. We have a very distributed health care system for good reason: It helps create trust and care continuity with neighborhood doctors, who can provide culturally competent care in their communities.

For approved vaccines that do not require special equipment, we should administer vaccinations in as many care settings as possible. The Moderna vaccine, for example, comes in small enough batches and can be stored in a regular fridge. We should make it generally available in doctors’ offices. 

Empower all health care providers to administer vaccines

To unlock the full capacity of our nations’ providers, we will need to grant a critical mass of local health care providers the ability to actually administer the vaccine. Health care professionals often talk about practicing at the “top of their license.” This is a saying that encourages medical providers of all kinds to up-level their work and utilize the full extent of their education and training. 

The vaccination program offers an opportunity for us to think creatively about providers practicing at the top of their license. Today, a patchwork of outdated state rules prevents many highly qualified health care professionals from getting access to and distributing the new vaccines. If we allow only primary-care physicians, internists, and pharmacists to administer a vaccine, we are closing ourselves off from critical pools of care supply. 

We should allow all qualified providers, regardless of specialty, to administer the vaccine. If we enable a much broader suite of specialists, including ob/gyns, dermatologists, ENTs, and even dentists, to vaccinate patients, we will flex our system’s capacity and reach herd immunity much more quickly. We will save lives.

Leverage patients’ trust in their providers

Many Americans are skeptical about the vaccine. Public health campaigns will certainly combat this skepticism by using government and public health officials, scientists, local leaders, and celebrities to help increase patients’ trust and willingness to take the vaccine. But we need to use every tool in our toolkit. 

Thankfully, local doctors have often spent decades building up trust with patients in their community. We need to leverage those long-standing relationships and build on the goodwill and trust that already exist between a patient and their doctor. These relationships are especially vital in minority communities. At Zocdoc, we are giving doctors and health systems access to free, easy-to-use vaccine scheduling software so that as supply becomes available, they have the technology they need to care for their patients during this critical time.

To further support this trusted provider network, state governments should provide medical professionals with clarity as to when the vaccine will be made available and how they should prioritize their patients. We also need to arm them with information and messaging that will enable them to communicate the safety and urgency of the vaccine to their patients. 

Perhaps most importantly, we need the vaccination process to feel familiar and routine to patients. The best way to do so is to make it as organic and woven into patients’ typical care experience as possible. For the average patient, it should feel no different than going to visit their doctor for a flu shot. 

Ultimately, I am optimistic that when we bring together the best and brightest minds to work on solving this complex problem, we can deliver a distribution system that matches scientists’ stellar achievements. And with a healthy dose of pragmatism, I have every confidence that we will be able to quickly defeat the virus and begin to return to normal.

Oliver Kharraz, MD, is the founder and CEO of Zocdoc.

About the Author
By Oliver Kharraz
See full bioRight Arrow Button Icon
Add Fortune on Google for similar content.

Latest in Commentary

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025

Most Popular

Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Finance
Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam
By Fortune Editors
October 20, 2025
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • World's Most Admired Companies
  • See All Rankings
  • Lists Calendar
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • About Us
  • Press Center
  • Work At Fortune
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

Latest in Commentary

nido
Commentary250 Years of Innovation
As an immigrant turned entrepreneur and college president, here is why I celebrate our nation as it turns 250
By Nido R. QubeinJune 25, 2026
17 hours ago
Asia’s defense boom is rewiring the global arms supply chain
Commentaryarms, weapons, and defense
Asia’s defense boom is rewiring the global arms supply chain
By Chris OberoiJune 24, 2026
1 day ago
steve
Commentary250 Years of Innovation
Steve Case: America was built by entrepreneurs. Here’s how we keep that edge for the next 250 years
By Steve CaseJune 24, 2026
2 days ago
t
CommentaryWhite House
Trump mistakes the bully pulpit for bullying leadership — history’s villains were never heroes
By Jeffrey Sonnenfeld and Steven TianJune 24, 2026
2 days ago
mg
CommentaryHealth
The ‘tech neck’ time bomb: why 43 million young Americans could cripple U.S. health care within a generation
By Michael GerlingJune 24, 2026
2 days ago
sb
Commentaryclimate change
The climate policy triangle: why leaders can no longer choose between growth, security and sustainability
By Sebastian BuckupJune 23, 2026
2 days ago

Most Popular

MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last year
Success
MacKenzie Scott alone accounted for one-third of America's $19.2 billion in megagifts last year
By Sydney LakeJune 25, 2026
21 hours ago
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic
Success
Now worth $200 million, Sarah Jessica Parker credits being ‘one of eight kids that struggled financially’ for her hunger, ambition, and work ethic
By Orianna Rosa RoyleJune 24, 2026
2 days ago
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurants
Success
Ikea’s billionaire founder was so frugal that he bought clothes from flea markets and took free salt and pepper from restaurants
By Orianna Rosa RoyleJune 25, 2026
21 hours ago
Current price of silver as of Thursday, June 25, 2026
Personal Finance
Current price of silver as of Thursday, June 25, 2026
By Joseph HostetlerJune 25, 2026
15 hours ago
Current price of oil as of June 25, 2026
Personal Finance
Current price of oil as of June 25, 2026
By Joseph HostetlerJune 25, 2026
15 hours ago
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
Success
After forcing workers back to the office, Goldman Sachs and JPMorgan Chase are now letting their staff work remotely—but only for the World Cup
By Orianna Rosa RoyleJune 23, 2026
3 days ago

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.